Bioorganic & Medicinal Chemistry Letters 2006-06-01

Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.

Balasubramanian Narasimhan, Vishnukant Mourya, Avinash Dhake

Index: Bioorg. Med. Chem. Lett. 16 , 3023-9, (2006)

Full Text: HTML

Abstract

A series of esters and amides of myristic acid was synthesized and tested in vitro for antibacterial activity against gram-positive and gram-negative bacteria. All the compounds showed activity comparable to that of the standard drug, ciprofloxacin. The structural characteristics governing antibacterial activity of myristic acid derivatives was studied using QSAR methodology. The results showed that the antibacterial activity could be modeled using the topological descriptor, valence molecular connectivity index. The predictive ability of the models was cross-validated by construction of a test set. The low residual activity and high cross-validated r2 values (r(cv)2) observed indicated the predictive ability of the developed QSAR models.

Related Compounds

Structure Name/CAS No. Articles
Isopropyl myristate Structure Isopropyl myristate
CAS:110-27-0
Methyl myristate Structure Methyl myristate
CAS:124-10-7
Ethyl tetradecanoate Structure Ethyl tetradecanoate
CAS:124-06-1
Myristic acid Structure Myristic acid
CAS:544-63-8
Ciprofloxacin Structure Ciprofloxacin
CAS:85721-33-1